PRESS RELEASE published on 05/21/2025 at 08:00, 1 year 5 months ago Informations privilégiées / Autres communiqués TME Pharma, société de biotechnologie spécialisée en thérapies contre le cancer, prolonge sa visibilité financière jusqu'en mai 2026 via une émission d'obligations aux investisseurs professionnels Investisseurs Obligations Cancer Visibilité Financière TME Pharma
BRIEF published on 04/10/2025 at 19:05, 1 year 6 months ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
BRIEF published on 04/10/2025 at 19:05, 1 year 6 months ago TME Pharma renforce son contrat de liquidité avec Invest Securities Contrat De Liquidité INVEST SECURITIES Marchés Financiers Oncologie TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 6 months ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 6 months ago Informations privilégiées / Autres communiqués TME Pharma augmente les ressources allouées au contrat de liquidité confié à Invest Securities pour renforcer la trésorerie. Détails des ressources disponibles après l'augmentation Contrat De Liquidité INVEST SECURITIES Trésorerie Ressources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 8 months ago TME Pharma présente sa feuille de route stratégique et ses initiatives pour 2025 Biotechnologie Partenariats Stratégiques Thérapie Contre Le Cancer Découverte De Médicaments NOX-A12
BRIEF published on 02/17/2025 at 08:05, 1 year 8 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 8 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 8 months ago TME Pharma et aimed analytics : Partenariat innovant pour la découverte de médicaments par l'IA Biotechnologie Partenariat Intelligence Artificielle Cancer Médicaments
BRIEF published on 01/29/2025 at 08:05, 1 year 8 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
Published on 10/28/2026 at 08:00, 2 hours 36 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 7 hours 41 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 7 hours 46 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 10 hours 56 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 11 hours 11 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 10:09, 27 minutes ago Finexity AG: FINEXITY AG successfully completes 1:4 stock split
Published on 10/28/2026 at 10:00, 36 minutes ago Original-Research: Zefiro Methane Corp. (von GBC AG): BUY
Published on 10/28/2026 at 10:00, 36 minutes ago EQS Group launches Q by EQS, its intelligence layer for compliance
Published on 10/28/2026 at 09:36, 1 hour ago Original-Research: Villeroy & Boch AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/28/2026 at 09:35, 1 hour 1 minute ago Farizon SV Model Year 2027 makes its French debut at Rungis, tested for real-world delivery
Published on 10/28/2026 at 08:00, 2 hours 36 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 2 hours 36 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 16 hours 36 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 16 hours 36 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
